Canada markets close in 1 hour 6 minutes

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.2000+0.0285 (+1.31%)
As of 02:04PM EST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
8,629
13,832
4,992
1,833
4,239
Selling General and Administrative
6,099
5,503
4,774
3,981
3,879
Total Operating Expenses
14,728
19,335
9,766
5,814
8,118
Operating Income or Loss
-14,728
-19,335
-9,766
-5,814
-8,118
Interest Expense
-
0
9
7
8
Income Before Tax
-14,428
-19,322
-9,747
-5,649
-7,964
Income Tax Expense
-
0
-9
-167
-31
Income from Continuing Operations
-14,428
-19,322
-9,738
-5,482
-7,933
Net Income
-14,428
-19,322
-9,738
-5,482
-7,931
Net Income available to common shareholders
-14,428
-19,322
-9,738
-5,482
-7,931
Basic EPS
-
-1.39
-2.07
-4.15
-10.26
Diluted EPS
-
-1.39
-2.07
-4.15
-10.26
Basic Average Shares
-
13,904
4,710
1,321
769.398
Diluted Average Shares
-
13,904
4,710
1,321
769.398
EBITDA
-
-19,231
-9,645
-5,553
-7,934